Co-Diagnostics, Inc. (CODX) financial statements (2021 and earlier)

Company profile

Business Address 4049 SOUTH HIGHLAND DRIVE
SALT LAKE CITY, UT 84124
State of Incorp. NY
Fiscal Year End December 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments8939503,534
Cash and cash equivalents8939503,534
Receivables13113 
Inventory, net of allowances, customer advances and progress billings197189
Inventory197189
Prepaid expense36370908
Total current assets:1,5841,0524,452
Noncurrent Assets
Property, plant and equipment197156166
Other undisclosed noncurrent assets43434545
Total noncurrent assets:631501210
TOTAL ASSETS:2,2151,5534,662
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities207323137
Accounts payable614941
Accrued liabilities20117497
Debt 1,909 
Due to related parties120120480
Deferred revenue and credits11
Other undisclosed current liabilities1  
Total current liabilities:3282,352628
Noncurrent Liabilities
Long-term debt and lease obligation, including:  278
Other undisclosed long-term debt and lease obligation  278
Liabilities, other than long-term debt150260184
Deferred revenue and credits184
Due to related parties150260 
Other undisclosed noncurrent liabilities  (278)
Total noncurrent liabilities:150260184
Total liabilities:4782,612812
Stockholders' equity
Stockholders' equity attributable to parent1,737(1,059)3,851
Preferred stock0  
Common stock171312
Additional paid in capital26,68817,62216,261
Accumulated deficit(24,968)(18,694)(12,422)
Total stockholders' equity:1,737(1,059)3,851
TOTAL LIABILITIES AND EQUITY:2,2151,5534,662

Income statement (P&L) ($ in thousands)

12/31/2019
12/31/2018
12/31/2017
Revenues215408
Revenue, net8
Cost of revenue(112)(9)(0)
Gross profit:103317
Operating expenses(5,996)(6,148)(4,571)
Operating loss:(5,894)(6,118)(4,564)
Nonoperating income (expense)(302)(154)4
Investment income, nonoperating  4
Other nonoperating expense(302)(154) 
Interest and debt expense(106)(135)(2,383)
Loss from continuing operations before equity method investments, income taxes:(6,302)(6,407)(6,943)
Other undisclosed income (loss) from continuing operations before income taxes106135(16)
Net loss available to common stockholders, diluted:(6,196)(6,272)(6,959)

Comprehensive Income ($ in thousands)

12/31/2019
12/31/2018
12/31/2017
Net loss:(6,196)(6,272)(6,959)
Comprehensive loss, net of tax, attributable to parent:(6,196)(6,272)(6,959)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: